NEKTAR THERAPEUTICS's ticker is and the CUSIP is 640268958. A total of 3 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,209 | +0.6% | 20,500 | -2.8% | 0.00% | – |
| Q2 2023 | $12,137 | +2585.2% | 21,100 | +10450.0% | 0.00% | – |
| Q4 2022 | $452 | -99.1% | 200 | -98.7% | 0.00% | – |
| Q3 2022 | $49,000 | -49.0% | 15,200 | -39.7% | 0.00% | – |
| Q2 2022 | $96,000 | -98.7% | 25,200 | -98.2% | 0.00% | -100.0% |
| Q1 2022 | $7,648,000 | +1662.2% | 1,419,000 | +4320.6% | 0.01% | – |
| Q4 2021 | $434,000 | +51.7% | 32,100 | +101.9% | 0.00% | – |
| Q3 2021 | $286,000 | -73.0% | 15,900 | -74.3% | 0.00% | -100.0% |
| Q2 2021 | $1,060,000 | +56.3% | 61,800 | +82.3% | 0.00% | 0.0% |
| Q1 2021 | $678,000 | -76.6% | 33,900 | -80.1% | 0.00% | -80.0% |
| Q4 2020 | $2,893,000 | +6.5% | 170,200 | +3.9% | 0.01% | -44.4% |
| Q3 2020 | $2,717,000 | -55.4% | 163,800 | -37.8% | 0.01% | -67.9% |
| Q2 2020 | $6,096,000 | +16.3% | 263,200 | -10.4% | 0.03% | -34.9% |
| Q1 2020 | $5,243,000 | -63.1% | 293,700 | -55.4% | 0.04% | -55.7% |
| Q4 2019 | $14,207,000 | +76.4% | 658,200 | +48.8% | 0.10% | +49.2% |
| Q3 2019 | $8,055,000 | +71.8% | 442,200 | +235.5% | 0.06% | +54.8% |
| Q2 2019 | $4,689,000 | +18.6% | 131,800 | +12.0% | 0.04% | -4.5% |
| Q1 2019 | $3,955,000 | +40.2% | 117,700 | +37.2% | 0.04% | +83.3% |
| Q4 2018 | $2,820,000 | -67.2% | 85,800 | -39.1% | 0.02% | -64.7% |
| Q3 2018 | $8,589,000 | -28.6% | 140,900 | -42.8% | 0.07% | -34.0% |
| Q2 2018 | $12,032,000 | +12.0% | 246,400 | +143.7% | 0.10% | -4.6% |
| Q1 2018 | $10,743,000 | +225.8% | 101,100 | +83.2% | 0.11% | +369.6% |
| Q4 2017 | $3,297,000 | +176.4% | 55,200 | +11.1% | 0.02% | +109.1% |
| Q3 2017 | $1,193,000 | -54.6% | 49,700 | -63.0% | 0.01% | -59.3% |
| Q2 2017 | $2,628,000 | -41.1% | 134,400 | -29.3% | 0.03% | -48.1% |
| Q1 2017 | $4,462,000 | +102.4% | 190,100 | +5.8% | 0.05% | +147.6% |
| Q4 2016 | $2,205,000 | +79.0% | 179,700 | +150.6% | 0.02% | +61.5% |
| Q3 2016 | $1,232,000 | +183.9% | 71,700 | +135.1% | 0.01% | +160.0% |
| Q2 2016 | $434,000 | +1450.0% | 30,500 | +1425.0% | 0.01% | – |
| Q1 2016 | $28,000 | -98.2% | 2,000 | -97.8% | 0.00% | -100.0% |
| Q4 2015 | $1,542,000 | +264.5% | 91,500 | +137.0% | 0.02% | +200.0% |
| Q3 2015 | $423,000 | -20.0% | 38,600 | -8.7% | 0.01% | -14.3% |
| Q2 2015 | $529,000 | -52.0% | 42,300 | -57.7% | 0.01% | -58.8% |
| Q1 2015 | $1,101,000 | +44.1% | 100,100 | +103.0% | 0.02% | +41.7% |
| Q4 2014 | $764,000 | +37.4% | 49,300 | +6.9% | 0.01% | +33.3% |
| Q3 2014 | $556,000 | -11.6% | 46,100 | -6.1% | 0.01% | -10.0% |
| Q2 2014 | $629,000 | +64.2% | 49,100 | +55.4% | 0.01% | +66.7% |
| Q1 2014 | $383,000 | -32.6% | 31,600 | -36.8% | 0.01% | -33.3% |
| Q4 2013 | $568,000 | -71.2% | 50,000 | -73.5% | 0.01% | -76.3% |
| Q3 2013 | $1,975,000 | +180.9% | 189,000 | +210.3% | 0.04% | +123.5% |
| Q2 2013 | $703,000 | – | 60,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 900 | $941,000 | 0.06% |
| GROUP ONE TRADING, L.P. | 189,000 | $1,975,000 | 0.04% |
| Citadel Advisors | 27,400 | $286,000 | 0.00% |